Voyager Therapeutics and Genzyme announced a major strategic collaboration to discover, develop and commercialize novel gene therapies for severe CNS disorders Read the full story

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Biopharma partners, Alnylam Pharmaceuticals and Genzyme, a subsidary of Sanofi, expand their long time collaboration by where Genzyme has invested $700 million in Alnylam.  Read the full story

Genzyme biotech deals AskBio in a licensing agreement for duplex gene therapy vector technology.  Read the full story

Workers at Sanofi, a top big pharma company had a message for politicians at protests in Paris this month Read the full story

This report provides all the information you require to better understand Genzyme and its partnering interests and activities over the past seven years. Read the full story

Genzyme, a pioneer in the development and delivery of transformative therapies for over 30 years, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Genzyme and Veracyte announced a global co-promotion partnership to provide a comprehensive solution for thyroid patients.

The arrangement will give patients worldwide increased access to an advanced personalized medicine solution for improved diagnosis of thyroid nodules, and the potential to significantly reduce the number of unnecessary thyroidectomies.  Read the full story

Don't look for Sanofi-Aventis to continue its dealmaking pace in the coming months. In fact, don't look for Sanofi-Aventis at all... Read the full story

Review of deals and alliances during February 2011. Read the full story